Interviews with Malaria Stakeholders
Topics:
All, Academia, Africa, Charity, Diagnosis, Drug Safety, Education, Entrepreneurship, Equality, Funding, Larvicides, Medicine, Mosquito Nets, New Technologies, Politics, Research & Development
Target Malaria is a consortium of researchers using ‘gene drives’ to fight malaria. I speak with Dr Alekos Simoni, one of their researchers based at Imperial College London.
Professor Marcia Castro from Harvard University helped launch MalariaX. It’s an online course that details the science and technology of malaria, as well as the historical, political, social and economic factors to its eradication.
Michelle Stanton is trying to reduce malaria deaths by better understanding where mosquito breeding spots are. She’s using the power of drones to capture aerial imagery in Malawi’s drone corridor – a patch of land devoted to humanitarian drone testing.
Dr Deborah O’Neil is the CEO of Novabiotics, a leading clinical-stage biotechnology company. She talks to me about antibiotic resistance and the future of pharma with so-called ‘personalised medicines’.
Access to healthcare can be extremely limited, with the nearest health facility located hours away. Transaid is using bicycle ambulances to transport mothers and children.
What makes a public health animation effective and, as the NHS introduces an online quiz to determine heart age, will such quizzes have a greater role in public health?
Dr Mike Coleman and Kirsten Duda of the Liverpool School of Tropical Medicine discuss their mobile game, Resistance 101, that aims to make concepts of insecticide resistance more accessible and engaging.